 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jan 31, 2022 |
| Title |
CRISPRa screen for drivers of COL7A1 expression in keratinocytes |
| Organisms |
Homo sapiens; synthetic construct |
| Experiment type |
Other
|
| Summary |
Background: Dystrophic epidermolysis bullosa (DEB) is a skin blistering disease caused by mutations in COL7A1, which encodes type VII collagen (C7). There is no cure for DEB, but previous work has shown potential therapeutic benefit in increasing production of even partially functional C7. Genome-wide screens using CRISPR-Cas9 have enabled the identification of genes involved in cancer development, drug resistance, and other genetic diseases, suggesting that they could be used to identify novel drivers of C7 production.
Methods: A keratinocyte C7 reporter cell line was created by integrating a tdTomato fluorescent marker into the last exon of the endogenous COL7A1 gene. A genome-wide CRISPR activation (CRISPRa) screen was performed with the C7_tdTomato reporter to identify genes and pathways that increase C7 expression. High tdTomato-expressing cells were sorted and sequenced to identify the single guide RNAs (sgRNAs) that became enriched relative to the starting material. Pathway analysis was performed on the corresponding genes to identify regulators and pathways that influence C7 expression. A targeted drug screen was performed in three different keratinocyte cell lines based on the CRISPRa screen results, and C7 upregulation was evaluated.
Results: The C7_tdTomato cell line was validated as an effective reporter cell line for detection of C7 upregulation. The CRISPRa screen identified two genes, DENND4B and TYROBP as top hits based on enrichment in the high fluorescence population and representation with multiple sgRNAs. Pathway analysis of the CRISPRa screen showed enrichment of toll-like receptor and interferon-related upstream regulators and functions related to calcium uptake and immune signaling. Several compounds in the targeted drug screen increased C7 expression in at least one keratinocyte line, but only kaempferol, a plant flavonoid, significantly increased C7 mRNA and protein in a DEB patient line.
Conclusions: The novel C7_tdTomato reporter cell line can be used to screen compounds for increased C7 expression. The CRISPRa screen combined with a fluorescent reporter cell line can be used to reveal mechanistic regulators of gene expression and therapeutic targets for rare genetic diseases. Kaempferol has shown promising results in increasing C7 production and should be further evaluated as a potential therapeutic for DEB patients.
|
| |
|
| Overall design |
A CRISPRa screen was performed on N/TERT keratinocytes with tdTomato inserted into the COL7A1 locus. Relative abundance of each sgRNA was calculated based on the input material (plasmid DNA).
|
| |
|
| Contributor(s) |
Pickett-Leonard MD, Thompson EL, Albert FW, Tolar J |
| Citation(s) |
35243691 |
| |
| Submission date |
Dec 10, 2020 |
| Last update date |
May 04, 2022 |
| Contact name |
Jakub Tolar |
| E-mail(s) |
tolar003@umn.edu
|
| Organization name |
University of Minnesota - Twin Cities
|
| Department |
Pediatrics
|
| Lab |
Stem Cell Institute
|
| Street address |
2001 6th St SE
|
| City |
Minneapolis |
| State/province |
Minnesota |
| ZIP/Postal code |
55455 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL22790 |
Illumina MiniSeq (Homo sapiens) |
| GPL26967 |
Illumina MiniSeq (synthetic construct) |
|
| Samples (2) |
|
| Relations |
| BioProject |
PRJNA684343 |
| SRA |
SRP297594 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE163024_COL7A1_CRISPRaScreen_Data.xlsx |
5.4 Mb |
(ftp)(http) |
XLSX |
| GSE163024_COL7A1_CRISPRaScreen_sgRNA.tabular.txt.gz |
128.4 Mb |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
